Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
PLoS One ; 14(12): e0225800, 2019.
Article de Anglais | MEDLINE | ID: mdl-31800600

RÉSUMÉ

Gastrointestinal illnesses are the most frequently diagnosed conditions among returning U.S. travelers. Although most episodes of travelers' diarrhea do not require antibiotic therapy, fluoroquinolones (a type of quinolone antibiotic) are recommended for treatment of moderate and severe travelers' diarrhea as well as many other types of severe infection. To assess associations between quinolone susceptibility and international travel, we linked data about isolate susceptibility in NARMS to cases of enteric infections reported to FoodNet. We categorized isolates as quinolone-nonsusceptible (QNS) if they were resistant or had intermediate susceptibility to ≥1 quinolone. Among 1,726 travel-associated infections reported to FoodNet with antimicrobial susceptibility data in NARMS during 2004-2014, 56% of isolates were quinolone-nonsusceptible, of which most (904/960) were Campylobacter. International travel was associated with >10-fold increased odds of infection with quinolone-nonsusceptible bacteria. Most QNS infections were associated with travel to Latin America and the Caribbean (390/743; 52%); however, the greatest risk of QNS infection was associated with travel to Africa (120 per 1,000,000 passenger journeys). Preventing acquisition and onward transmission of antimicrobial-resistant enteric infections among travelers is critical.


Sujet(s)
Résistance microbienne aux médicaments , Maladies d'origine alimentaire/épidémiologie , Maladies d'origine alimentaire/microbiologie , Maladies intestinales/épidémiologie , Maladies intestinales/microbiologie , Quinolinone/pharmacologie , Maladie liée aux voyages , Voyage , Maladies d'origine alimentaire/traitement médicamenteux , Maladies d'origine alimentaire/histoire , Histoire du 21ème siècle , Humains , Maladies intestinales/traitement médicamenteux , Maladies intestinales/histoire , Odds ratio , Surveillance de la population , États-Unis/épidémiologie
2.
Foodborne Pathog Dis ; 15(11): 701-704, 2018 11.
Article de Anglais | MEDLINE | ID: mdl-30153043

RÉSUMÉ

We tested a diverse set of 500 isolates of nontyphoidal Salmonella enterica subsp. enterica from various animal, food, and human clinical sources for susceptibility to antimicrobials currently lacking epidemiological cutoff values (ECOFFs) set by the European Committee on Antimicrobial Susceptibility Testing. A consortium of five different laboratories each tested 100 isolates, using broth microdilution panels containing twofold dilutions of ceftriaxone, cefepime, and colistin to determine the minimum inhibitory concentrations of each drug when tested against the Salmonella isolates. Based on the resulting data, new ECOFFs of 0.25 µg/mL for ceftriaxone, 0.12 µg/mL for cefepime, and 2 µg/mL for colistin have been proposed. These thresholds will aid in the identification of Salmonella that have phenotypically detectable resistance mechanisms to these important antimicrobials.


Sujet(s)
Céfépime/pharmacologie , Ceftriaxone/pharmacologie , Colistine/pharmacologie , Résistance bactérienne aux médicaments , Tests de sensibilité microbienne/normes , Salmonella enterica/effets des médicaments et des substances chimiques , Animaux , Antibactériens/pharmacologie , Humains , Salmonella enterica/isolement et purification , États-Unis
3.
PLoS One ; 13(12): e0208735, 2018.
Article de Anglais | MEDLINE | ID: mdl-30596673

RÉSUMÉ

Enterotoxigenic Escherichia coli (ETEC) are an important cause of diarrhea globally, particularly among children under the age of five in developing countries. ETEC O6 is the most common ETEC serogroup, yet the genome wide population structure of isolates of this serogroup is yet to be determined. In this study, we have characterized 40 ETEC O6 isolates collected between 1975-2016 by whole genome sequencing (WGS) and by phenotypic antimicrobial susceptibility testing. To determine the relatedness of isolates, we evaluated two methods-whole genome high-quality single nucleotide polymorphism (whole genome-hqSNP) and core genome SNP analyses using Lyve-SET and Parsnp respectively. All isolates were tested for antimicrobial susceptibility using a panel of 14 antibiotics. ResFinder 2.1 and a custom quinolone resistance determinants workflow were used for resistance determinant detection. VirulenceFinder 1.5 was used for prediction of the virulence genes. Thirty-seven isolates clustered into three major clades (I, II, III) by whole genome-hqSNP and core genome SNP analyses, while three isolates included in the whole genome-hqSNP analysis only did not cluster with clades I-III by both analyses and formed a distantly related outgroup, designated clade IV. Median number of pairwise whole genome-hqSNPs in clonal ETEC O6 outbreaks ranged from 0 to 5. Of the 40 isolates tested for antimicrobial susceptibility, 18 isolates were pansusceptible. Twenty-two isolates were resistant to at least one antibiotic, nine of which were multidrug resistant. Phenotypic antimicrobial resistance (AR) correlated with AR determinants in 22 isolates. Thirty-two isolates harbored both enterotoxin virulence genes while the remaining 8 isolates had only one of the two virulence genes. In summary, whole genome-hqSNP and core genome SNP analyses from this study revealed similar evolutionary relationships and an overall diversity of ETEC O6 isolates independent of time of isolation. Less than 5 pairwise hqSNPs between ETEC O6 isolates is circumstantially indicative of an outbreak cluster. Findings from this study will be a basis for quicker outbreak detection and control by efficient subtyping by WGS.


Sujet(s)
Escherichia coli entérotoxigène/génétique , Infections à Escherichia coli/épidémiologie , Infections à Escherichia coli/microbiologie , Antibactériens/pharmacologie , Biologie informatique , ADN bactérien , Épidémies de maladies , Résistance bactérienne aux médicaments/génétique , Escherichia coli entérotoxigène/effets des médicaments et des substances chimiques , Escherichia coli entérotoxigène/isolement et purification , Escherichia coli entérotoxigène/pathogénicité , Génome bactérien , Humains , Tests de sensibilité microbienne , Polymorphisme de nucléotide simple , Analyse de séquence d'ADN , Sérogroupe , Facteurs de virulence/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE